| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM090860 | Implementing the Zero Suicide Framework at Carrier Clinic to Strengthen Suicide Prevention Capacity | 000 | 1 | SAMHSA | 10/13/2026 | $0 |
| | 2027 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI171401 | Metropolitan AntiViral Drug Accelerator | 000 | 2 | NIH | 10/15/2026 | $0 |
| | 2027 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K00CA264409 | Optimizing adherence to lung cancer screening: Applying theory and implementation science to participant engagement | 001 | 5 | NIH | 10/27/2026 | $2 |
| | 2027 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K00CA264409 | Optimizing adherence to lung cancer screening: Applying theory and implementation science to participant engagement | 000 | 5 | NIH | 10/20/2026 | -$2 |
|
| Issue Date FY: 2026 ( Subtotal = $44,512,828 ) (Continued on the next page) |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA283566 | Nuclear envelope and predisposition to hepatic neoplasia | 000 | 5 | NIH | 7/7/2026 | $405,116 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI190958 | Effects of antifungal drug treatment and immune dysfunction on the evolutionary dynamics of gut-colonizing Candida glabrata | 000 | 2 | NIH | 1/26/2026 | $221,375 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI112579 | Regulation of T cell exhaustion via 3D chromatin architecture | 001 | 11 | NIH | 5/4/2026 | $624,311 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UH3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO) | 001 | 4 | NIH | 7/16/2026 | $5,168,081 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI189168 | Center for accelerated development of drug candidates targeting high threat bacterial infections | 000 | 2 | NIH | 9/15/2026 | $7,562,521 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI173261 | Celiac and inflammatory bowel diseases: functional post-GWAS approach | 000 | 3 | NIH | 8/18/2026 | $889,388 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA290808 | ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection | 000 | 3 | NIH | 4/27/2026 | $733,555 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 002 | 4 | SAMHSA | 6/26/2026 | $374,129 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01MH134474 | Can an Evidence-Based Mental Health Intervention be Implemented into Preexisting Home Visiting Programs using Implementation Facilitation? | 001 | 3 | NIH | 9/17/2026 | $817,652 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2554943 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/21/2026 | $398,569 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K22CA288932 | Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) among Patients with Cancer. | 000 | 3 | NIH | 6/11/2026 | $194,400 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI177342 | Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease | 000 | 4 | NIH | 6/1/2026 | $838,280 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI171401 | Metropolitan AntiViral Drug Accelerator | 002 | 2 | NIH | 9/17/2026 | $13,895,048 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI132374 | Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease | 000 | 9 | NIH | 4/21/2026 | $872,777 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI121080 | CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity | 000 | 10 | NIH | 9/4/2026 | $523,039 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI184502 | Shorter and more effective oral regimens for M. abscessus pulmonary disease | 000 | 2 | NIH | 1/28/2026 | $856,988 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 000 | 5 | NIH | 1/26/2026 | $485,503 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 001 | 5 | NIH | 4/16/2026 | $53,945 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI182977 | Tissue specific immunity to fungal infections | 000 | 2 | NIH | 11/26/2025 | $883,729 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI187674 | C25-modified rifabutin analogs as a novel medicinal chemistry strategy to overcome drug-resistant tuberculosis | 000 | 2 | NIH | 1/9/2026 | $221,375 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 02 | 7 | CMS | 6/26/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 01 | 7 | CMS | 5/14/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 00 | 7 | CMS | 12/19/2025 | $1,615,000 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2256166 | Dental Reimbursement Program | 00 | 1 | HRSA | 9/11/2026 | $154,172 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI089583 | HMH Jersey Shore Paths to Recovery (P2R) | 000 | 1 | SAMHSA | 9/18/2026 | $750,000 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R61HL185680 | Safety and Pharmacodynamics of L-Citrulline for the Treatment of Pulmonary Hypertension (PH) in Preterm Neonates with Severe Bronchopulmonary Dysplasia (BPD-PH) [CToP BPD-PH] | 000 | 1 | NIH | 9/4/2026 | $470,687 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K01CA308858 | Peer Coaching for Digital Health Engagement Among Adolescent and Young Adult (AYA) Cancer Survivors | 000 | 1 | NIH | 8/17/2026 | $192,240 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA309638 | Identifying Predictive and Prognostic Adipome Biomarkers in Obese TNBC Mice for Targeted Therapy Development | 000 | 1 | NIH | 7/16/2026 | $460,254 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA293616 | Myeloid Phagocyte Activation by Commensal-Activated Complement C5aR1 Signaling: Implications for Tumor-Directed Lymphocyte Response | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA293616 | Myeloid Phagocyte Activation by Commensal-Activated Complement C5aR1 Signaling: Implications for Tumor-Directed Lymphocyte Response | 000 | 1 | NIH | 4/29/2026 | $467,261 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI088571 | Screening, Brief Intervention and Referral to Treatment | 000 | 1 | SAMHSA | 8/28/2026 | $995,000 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA315494 | CLEAR-Lung: Community-Level Effectiveness to Advance Reach in Lung Cancer Screening | 000 | 1 | NIH | 7/17/2026 | $769,923 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM090860 | Implementing the Zero Suicide Framework at Carrier Clinic to Strengthen Suicide Prevention Capacity | 000 | 1 | SAMHSA | 7/27/2026 | $400,000 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 000 | 4 | NIH | 3/9/2026 | $706,026 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U01AI187297 | Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniae | 000 | 2 | NIH | 6/23/2026 | $862,153 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI141805 | Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex | 000 | 6 | NIH | 6/30/2026 | $839,368 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 005 | 2 | NIH | 6/4/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UH3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO) | 000 | 3 | NIH | 4/22/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 001 | 3 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 000 | 3 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2554943 | Addiction Medicine Fellowship | 02 | 1 | HRSA | 3/5/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K00CA264409 | Optimizing adherence to lung cancer screening: Applying theory and implementation science to participant engagement | 000 | 5 | NIH | 9/3/2026 | -$107,060 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 002 | 5 | SAMHSA | 5/12/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
|
